Laboratory Corporation of America Holdings (LAB.F)
| Previous close | 194.00 |
| Open | 193.00 |
| Bid | 184.00 x 10000 |
| Ask | 185.00 x 10000 |
| Day's range | 185.00 - 193.00 |
| 52-week range | 167.72 - 212.00 |
| Volume | |
| Avg. volume | 4 |
| Market cap | 15.586B |
| Beta (5Y monthly) | 1.00 |
| PE ratio (TTM) | 45.68 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.68 (1.38%) |
| Ex-dividend date | 28 May 2024 |
| 1y target est | N/A |
- GuruFocus.com
Laboratory Corp of America Holdings (LH) Q1 Earnings: Surpasses Revenue Forecasts and Updates ...
Robust Performance Amid Expansions and Strategic Acquisitions
- Reuters
Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 million
Labcorp will acquire all of the bankrupt firm's assets on a going concern basis for $239 million in cash consideration and other non-cash consideration, the companies said in separate statements. In February, Invitae filed for voluntary Chapter 11 protection in a U.S. bankruptcy court and said that it intended to pursue a sale process. Invitae's estimated assets were in the $500 million - $1 billion range, while its liabilities were in the $1 billion - $10 billion range, according to the bankruptcy filing.
- Reuters
Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln
Laboratory service provider Labcorp said on Wednesday it will acquire Softbank-backed Invitae Corp's assets auctioned through a voluntary bankruptcy protection process, a few months after the genetic test maker filed for bankruptcy. Labcorp will acquire all of the bankrupt firm's assets on a going concern basis for $239 million in cash consideration and other non-cash consideration, the companies said in separate statements. In February, Invitae filed for voluntary Chapter 11 protection in a U.S. bankruptcy court and said that it intended to pursue a sale process.
